The clinical course of Brugada syndrome (BrS) in children and adolescents is incompletely defined due to the rarity of the phenotype in the first decades of life. In 2007, Probst… Click to show full abstract
The clinical course of Brugada syndrome (BrS) in children and adolescents is incompletely defined due to the rarity of the phenotype in the first decades of life. In 2007, Probst et al. [(1)][1] reported the outcome of 30 pediatric patients with 3 years of follow-up, who experienced a 3% annual
               
Click one of the above tabs to view related content.